CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Clinical trials for CHEMOTHERAPY INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for young cancer patients: drug aims to fix dangerous low platelet counts from chemo
Disease control Recruiting nowThis study tests a drug called romiplostim N01 in children and young adults (ages 6-24) whose platelet counts drop dangerously low after chemotherapy. The goal is to see if weekly injections can safely bring platelet levels back up within three weeks. About 50 participants will r…
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 02:15 UTC
-
New combo aims to fix chemo side effect that leaves cancer survivors at risk of bleeding
Disease control Recruiting nowThis study tests whether adding a vitamin A-like drug (ATRA) to a platelet-boosting medication (romiplostim N01) works better than the platelet drug alone for cancer survivors whose platelet counts stay low after chemotherapy. About 220 adults with gynecologic, breast, or lung ca…
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New combo aims to fix chemo side effect in cancer survivors
Disease control Recruiting nowThis study is for adults who have finished chemotherapy for gastrointestinal cancer and are in remission, but still have dangerously low platelet counts. Researchers want to see if adding a second drug (ATRA) to the standard platelet-boosting drug (romiplostim N01) works better t…
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Can a platelet booster keep chemo on track for kids with ewing sarcoma?
Symptom relief Recruiting nowThis study tests whether the drug romiplostim can prevent dangerously low platelet counts caused by chemotherapy in children and young adults with newly diagnosed Ewing sarcoma. About 26 participants will receive romiplostim alongside their standard chemotherapy to see if it help…
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated May 26, 2026 02:19 UTC
-
Home blood tests could spare cancer patients unnecessary hospital trips
Knowledge-focused Recruiting nowThis study is testing whether cancer patients undergoing chemotherapy can monitor their own blood counts at home instead of traveling to the hospital for every blood draw. About 265 adults with cancer from Denmark, Poland, and Germany will participate. The goal is to see if home …
Matched conditions: CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Sponsor: Pomeranian Medical University Szczecin • Aim: Knowledge-focused
Last updated May 26, 2026 02:23 UTC